21323 Lexapro Statistical PREA

First Page		Document Content
Pharmacology Research Design of experiments Evaluation methods Bioethics Escitalopram Placebo-controlled study Clinical trial Placebo Medicine Science Clinical research		21323 Lexapro Statistical PREA Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 772,28 KB Share Document on Facebook

	Results of the Randomized, Double-Blind, Placebo-Controlled, Phase 3 Hercules Study of Caplacizumab in Patients with Acquired Thrombotic Thrombocytopenic Purpura Marie Scully, Spero Cataland, Flora Peyvandi, Paul Coppo, DocID: 1utac - View Document
	Clin Exp Allergy 2002; 32:928±932 A double-blind, placebo-controlled study on the diagnostic accuracy of an electrodermal test in allergic subjects M. Semizzi, G. Senna, M. Crivellaro, G. Rapacioli{, G. Passalacqua{, DocID: 1t7cl - View Document
	A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Niraparib Maintenance Treatment in Patients with HRD-Positive Advanced Ovarian Cancer Following Response on Front-Line Platinum-Based Chemothe DocID: 1rDJY - View Document
	Press release from the International Council for Homeopathy ICH is the international professional platform representing the interests of 32 national associations of professional homeopathy practitioners in 30 Countries DocID: 1qj7u - View Document
	TRIUMPH I study: Double Blind Placebo Controlled Clinical Investigation into the Efficacy and Tolerability of Inhaled Treprostinil Sodium in Patients with Severe Pulmonary Arterial Hypertension DocID: 1oueC - View Document